Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02955290
What this trial is testing

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

Who this might be right for
Advanced Head and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell Carcinoma+13 more
Roswell Park Cancer Institute 51
Large-scale testing (Phase 3)Ended earlyNCT03199885
What this trial is testing

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast AdenocarcinomaMetastatic HER2-Positive Breast CarcinomaRecurrent Breast Adenocarcinoma+5 more
National Cancer Institute (NCI) 190
Testing effectiveness (Phase 2)Study completedNCT06226350
What this trial is testing

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

Who this might be right for
Cervical Cancer
Shandong New Time Pharmaceutical Co., LTD 29
Not applicableWithdrawnNCT04084431
What this trial is testing

Supportive Care With or Without Repeated Whole Brain Radiotherapy in Patients With Recurrent Brain Metastases

Who this might be right for
Brain Metastases
University Hospital Heidelberg
Testing effectiveness (Phase 2)Study completedNCT00118157
What this trial is testing

Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen

Who this might be right for
Estrogen Receptor PositiveMale Breast CarcinomaProgesterone Receptor Positive+4 more
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Study completedNCT00556712
What this trial is testing

Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 889
Large-scale testing (Phase 3)Study completedNCT00403065
What this trial is testing

Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery

Who this might be right for
Lung CancerMetastatic Cancer
Medical Research Council 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06769152
What this trial is testing

A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors

Who this might be right for
Cervical CancerOvarian Cancer
Shanghai Henlius Biotech 190
Testing effectiveness (Phase 2)UnknownNCT05551247
What this trial is testing

Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 30
Large-scale testing (Phase 3)Looking for participantsNCT07294508
What this trial is testing

Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer

Who this might be right for
HER2 + Breast Cancer
Shanghai Henlius Biotech 706
Testing effectiveness (Phase 2)Study completedNCT00003989
What this trial is testing

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Who this might be right for
Lung CancerMelanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 50
Large-scale testing (Phase 3)Study completedNCT00004252
What this trial is testing

Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Pfizer
Early research (Phase 1)Study completedNCT04316689
What this trial is testing

First-in-human Study of S-588210 (S-488210+S-488211)

Who this might be right for
Lung CancerHead and Neck CancerBladder Cancer+2 more
Shionogi 10
Testing effectiveness (Phase 2)Study completedNCT04405349
What this trial is testing

Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer

Who this might be right for
Cervical CancerCervix Cancer
Nykode Therapeutics ASA 52
Testing effectiveness (Phase 2)Ended earlyNCT00138125
What this trial is testing

Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Translational Oncology Research International 2
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01703754
What this trial is testing

Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.

Who this might be right for
Breast Cancer Nos Metastatic Recurrent
Alaunos Therapeutics 12
Testing effectiveness (Phase 2)Study completedNCT00238329
What this trial is testing

PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Barbara Ann Karmanos Cancer Institute 32
Large-scale testing (Phase 3)Study completedNCT01986569
What this trial is testing

Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer

Who this might be right for
Recurrent Breast CancerStage IV Breast Cancer
Asan Medical Center 93
Testing effectiveness (Phase 2)Study completedNCT00077402
What this trial is testing

Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cancer Therapeutics Research Group 50
Next Page